What is the main topic of the JPI seminar scheduled for April 9th?

The seminar will focus on building a drug discovery ecosystem in Japan and measures to promote clinical trials, as explained by a director from the Ministry of Health, Labour and Welfare.

What significant problem in Japan's pharmaceutical landscape will the seminar address?

The seminar will address the 'drug loss' problem, where medicines approved in Europe and the United States are not developed in Japan, risking the non-provision of innovative medicines.

What are the key objectives of the public and private sector collaboration discussed in the seminar?

The key objectives are to strengthen Japan's drug discovery capabilities, ensure the rapid delivery of the latest medicines to the public, and build a sustainable cycle of investment and innovation.

What specific areas will Mr. Araki's lecture cover regarding drug discovery and clinical trials in Japan?

Mr. Araki's lecture will cover the current status of drug loss in Japan, policies for building a drug discovery ecosystem, and the Ministry of Health, Labour and Welfare's efforts and measures to promote clinical trials.

AI News NQ Analysis

[JPI Seminar] Ministry of Health, Labour and Welfare "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials" to be held on Thursday, April 9th

NQ Score 59/100

Key facts

[JPI Seminar] Ministry of Health, Labour and Welfare "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials" to be held on Thursday, April 9th
JPI (Japan Planning Institute) will hold a seminar inviting Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare, to explain in detail about building a drug discovery ecosystem and measures to promote clinical trials. [Details and Registration] https://www.jpi.co.jp/seminar/17693 [Title] The Deepening "Drug Loss" Problem and Strengthening Japan's Drug Discovery Capabilities Mini
Date: Mon Mar 30 2026 11:04:50 GMT+0900 (Japan Standard Time)

Direct answer

JPI (Japan Planning Institute) will hold a seminar inviting Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare, to explain in detail about building a drug discovery ecosystem and measures to promote clinical trials. [Details and Registration] https://www.jpi.co.jp/seminar/17693 [Title] The Deepening "Drug Loss" Problem and Strengthening Japan's Drug Discovery Capabilities Mini

Citation: [JPI Seminar] Ministry of Health, Labour and Welfare "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials" to be held on Thursday, April 9th (Mon Mar 30 2026 11:04:50 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Mon Mar 30 2026 11:04:50 GMT+0900 (Japan Standard Time)

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the main topic of the JPI seminar scheduled for April 9th?: A: The seminar will focus on building a drug discovery ecosystem in Japan and measures to promote clinical trials, as explained by a director from the Ministry of Health, Labour and Welfare.
Q: Who is the featured speaker at the JPI seminar on drug discovery?: A: The featured speaker is Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare.
Q: What significant problem in Japan's pharmaceutical landscape will the seminar address?: A: The seminar will address the 'drug loss' problem, where medicines approved in Europe and the United States are not developed in Japan, risking the non-provision of innovative medicines.
Q: What are the key objectives of the public and private sector collaboration discussed in the seminar?: A: The key objectives are to strengthen Japan's drug discovery capabilities, ensure the rapid delivery of the latest medicines to the public, and build a sustainable cycle of investment and innovation.
Q: What specific areas will Mr. Araki's lecture cover regarding drug discovery and clinical trials in Japan?: A: Mr. Araki's lecture will cover the current status of drug loss in Japan, policies for building a drug discovery ecosystem, and the Ministry of Health, Labour and Welfare's efforts and measures to promote clinical trials.